HIV/HCV Co-infection and the risk
of Cardiovascular Disease: A Meta-analysis.
Osibogun O, Ogunmoroti O, Michos ED, et al
J Viral Hepat. 2017 May
14.
Abstract
Metabolic and Cardiovascular Complications in
HIV/HCV-Co-infected Patients.
Bedimo R, Abodunde O.
Curr HIV/AIDS Rep.
2016 Sep 5
Abstract
Giant cell aortitis in treatment-naive human
immunodeficiency virus and hepatitis C coinfection.
Konstantinidou MK, Nelson M, Rosendahl U, Asimakopoulos G.
Ann R Coll Surg Engl.
2016 Aug 9:e1-e3.
Abstract
Coronary Heart Disease Risk by Framingham Risk
Score in Hepatitis C and HIV/Hepatitis C Coinfected Persons.
Chew KW, Bhattacharya
D, McGinnis K, et al
AIDS Res Hum Retroviruses.
2015 Apr 9.
Abstract
Risk of cardiovascular disease in HIV, hepatitis C,
or HIV/hepatitis C patients compared to the general population.
Kakinami L, Block RC, Adams MJ, et al
Int J Clin Pract. 2013
Jan;67(1):6-13.
Abstract
Into the wardrobe of Narnia: beyond HIV infection a
world of cardiovascular risk.
Colotto M, Renzi A, Durante C.
BMJ Case Rep.
2012 Jul 17;2012.
Abstract
FULL-TEXT PDF
ARTICLE
Evaluation of endothelial function and subclinical atherosclerosis
in association with hepatitis C virus in HIV-infected patients: a
cross-sectional study.
Masia M, Padilla S, Robledano C, Ramos JM, Gutierrez F.
et al
BMC Infect Dis.
2011 Oct 3;11(1):265
Paper
Accelerated coronary atherosclerosis after execution of
percutaneous coronary intervention
in patient with HIV/HCV coinfection: case report and review of the
literature.
Ceccarelli G, d'Ettorre G, Mancone M, et al
Cardiovasc Revasc Med.
2011 Jan 25
Abstract
Is statin therapy safe in patients with
HIV/hepatitis C coinfection?
Stroup JS, Harris B.
Proc (Bayl Univ Med Cent).
2010 Apr;23(2):111-3
Abstract
Hepatitis C virus infection is associated with endothelial dysfunction in
HIV/hepatitis C
virus coinfected patients.
Castro IF, Micheloud D, Berenguer J, et al
AIDS. 2010 Jul 7
Abstract |